Search

Your search keyword '"Cotter, Gad"' showing total 105 results

Search Constraints

Start Over You searched for: Author "Cotter, Gad" Remove constraint Author: "Cotter, Gad" Publisher elsevier bv Remove constraint Publisher: elsevier bv
105 results on '"Cotter, Gad"'

Search Results

1. Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial

2. Safety Indicators In Patients Receiving High-intensity Care After Acute Heart Failure Admission: The STRONG-HF Trial

3. Objectively measured medication adherence using assays for carvedilol and enalaprilat in patients with heart failure in Mozambique and Nigeria

4. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial

6. Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction

7. Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock

10. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

11. Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)

12. Early echocardiography by treating physicians and outcome in the critically ill: An ancillary study from the prospective multicenter trial FROG-ICU

13. Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure

14. Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry

15. Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation

16. Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials

17. The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart Failure

18. Cause of Death in Patients With Acute Heart Failure

22. Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study

23. Trajectories of Changes in Renal Function in Patients with Acute Heart Failure

25. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure

26. Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF

27. Symptoms and Signs of Heart Failure at Admission and Discharge and Outcomes in the Sub-Saharan Acute Heart Failure (THESUS-HF) Registry

28. Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial

29. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction

30. Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial

31. Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure

32. Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)

34. Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure

35. Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure — Post-hoc analysis of the PROTECT trial

36. Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS

37. Acute heart failure in the young: Clinical characteristics and biomarker profiles

38. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR

39. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes

40. HETEROGENEITY IN EFFICACY OF ROLOFYLLINE USING A RISK-BASED EVALUATION IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE

42. Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients

43. MicroRNAs relate to early worsening of renal function in patients with acute heart failure

44. Prediction of Post-Discharge Outcomes for Patients Hospitalized with Heart Failure: Results from PROTECT

45. Worsening Heart Failure Following Admission for Acute Heart Failure

46. TAILORING THERAPY IN ACUTE HEART FAILURE: CAN BIOMARKERS DISTINGUISH RESPONDERS FROM NON-RESPONDERS?

47. Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study

48. Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor

49. Effect of Serelaxin on Mode of Death in Acute Heart Failure

50. Liver Function, In-Hospital, and Post-Discharge Clinical Outcome in Patients With Acute Heart Failure—Results From the Relaxin for the Treatment of Patients With Acute Heart Failure Study

Catalog

Books, media, physical & digital resources